Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Stock on nice roll - up .07 to .18C
View:
Post by jcjohn36 on Jan 30, 2019 3:38pm

Stock on nice roll - up .07 to .18C

Great day for SP. Fingers crossed. Some news out yesterday. They announced that it has dosed the first cohort of patient with COTI-2 in combination with standard of care chemotherapy in its ongoing Phase 1b/2a trial. Cheers, JC
Comment by Cotitwo on Feb 02, 2019 2:30pm
Just to clarify if need be all 3 patients have been dosed in Cohort 1  The first patient was dosed on Jan 14 which would mean he/she would of completed 3 weeks The other 2 started this past Monday so there done Feb 15 Once the 3 people have completed there 3 week cycle Cohort 2 can begin there cycle at a higher dose. The company sent out an email yesterday inviting Existing and Potential ...more  
Comment by monkeydancer on Feb 09, 2019 11:07am
Not a penny from me. Seeing my investment managed to a 97 percent loss after they consolidated shares with no news to speak of to support is indicative of intent to wipe out old shareholders or complete ignorance / incompetence IMO. How does the BOD agree with these actions? All accountable, and all should be gone. They can invite whomever they wish to a meeting and promise the world but I expect ...more  
Comment by TrueNorth911 on Feb 09, 2019 3:51pm
Agree 997%...which is about what I've lost on this dog. If they were to release some positive news, and see the stock shoot up to a couple bucks, I might approach, contemplating the consideration of giving them $. But we must protect the IP so that this BOD doesn't steal the company from underneath us. Not going to throw any more good $ chasing the bad $ I've already given them ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities